Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Neff

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Blood|October 21, 2004
Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapyTobias Neff, Brian C Beard, Laura J Peterson, et al.
Plos Genetics|September 15, 2018
Activating PAX gene family paralogs to complement PAX5 leukemia driver mutationsMatthew R Hart, Donovan J Anderson, Christopher C Porter, et al.
Nature Chemical Biology|August 27, 2013
Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancerWoojin Kim, Gregory H Bird, Tobias Neff, et al.
Blood|January 24, 2004
Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocolPeter A Horn, Kirsten A Keyser, Laura J Peterson, et al.
Experimental Hematology|June 26, 2007
Hematopoietic stem cell engraftment: a direct comparison between intramarrow and intravenous injection in nonhuman primatesChul Won Jung, Brian C Beard, Julia C Morris, et al.
Blood|April 2, 2009
Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipientsBrian C Beard, Reeteka Sud, Kirsten A Keyser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cellsTobias Neff, Laura J Peterson, Julia C Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2012
Polycomb repressive complex 2 is required for MLL-AF9 leukemiaTobias Neff, Amit U Sinha, Michael J Kluk, et al.
Science Translational Medicine|May 11, 2012
Extended survival of glioblastoma patients after chemoprotective HSC gene therapyJennifer E Adair, Brian C Beard, Grant D Trobridge, et al.
Cancer Cell|June 14, 2017
MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid LeukemiaYufei Chen, Konstantinos Anastassiadis, Andrea Kranz, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Blood|October 21, 2004
Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapyTobias Neff, Brian C Beard, Laura J Peterson, et al.
Plos Genetics|September 15, 2018
Activating PAX gene family paralogs to complement PAX5 leukemia driver mutationsMatthew R Hart, Donovan J Anderson, Christopher C Porter, et al.
Nature Chemical Biology|August 27, 2013
Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancerWoojin Kim, Gregory H Bird, Tobias Neff, et al.
Blood|January 24, 2004
Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocolPeter A Horn, Kirsten A Keyser, Laura J Peterson, et al.
Experimental Hematology|June 26, 2007
Hematopoietic stem cell engraftment: a direct comparison between intramarrow and intravenous injection in nonhuman primatesChul Won Jung, Brian C Beard, Julia C Morris, et al.
Blood|April 2, 2009
Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipientsBrian C Beard, Reeteka Sud, Kirsten A Keyser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cellsTobias Neff, Laura J Peterson, Julia C Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2012
Polycomb repressive complex 2 is required for MLL-AF9 leukemiaTobias Neff, Amit U Sinha, Michael J Kluk, et al.
Science Translational Medicine|May 11, 2012
Extended survival of glioblastoma patients after chemoprotective HSC gene therapyJennifer E Adair, Brian C Beard, Grant D Trobridge, et al.
Cancer Cell|June 14, 2017
MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid LeukemiaYufei Chen, Konstantinos Anastassiadis, Andrea Kranz, et al.
Pageof 4